Known risks include injection-site reactions, water retention with GH peptides, potential interactions with existing medications, and theoretical concerns around telomerase activation in the context of cancer risk
Over time, pharmacological engineering enabled: Short-acting injectables (e.g., exenatide) Long-acting once-weekly injectables (liraglutide, semaglutide) Multi-target incretin therapies (tirzepatide) Oral peptide formulations and now oral small molecules The most recent breakthrough is the development of orally available GLP-1 receptor agonists, including: Orforglipron (Lilly) Elecoglipron (AstraZeneca) These compounds eliminate the need for injection and could dramatically expand accessibility and adherence in obesity and diabetes populations
A sore or smooth tongue
Est demostrado que algunos alimentos estimulan su produccin y potencian sus efectos: control del apetito, menos hambre y mayor saciedad, entre otros
Use supplements as needed
Today, theyre widely used for medical weight loss due to their effects on appetite and metabolism